The National Institutes of Health (NIH) intends to award a non-competitive, brand-name service contract to Illumina, Inc. for the maintenance and support of Illumina sequencers at the NIH Intramural Sequencing Center (NISC) in Bethesda, Maryland. These sequencers are vital to NISC’s high-throughput DNA sequencing operations, and the contract ensures they remain operational to support timely research. The procurement is conducted under simplified acquisition procedures, with a budget not exceeding the simplified acquisition threshold of $350,000. Responses from interested parties must be received by May 22, 2026, at 9:00 AM Eastern time. Performance of services will take place at the NIH facility in Bethesda, Maryland.